SCHIMMEL PAUL

Track

Insider profile

Performance

Overall performance
1.6
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -17% 8.2% 15.1%
Success rate 11% 68% 82%
Transactions
4 75% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -14%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
SCHIMMEL PAUL's trades of aTyr Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-28 2026-05-27
B Purchase
77,855 -7.7%
331.31
US$4,096,121 		77,855 -7.7% 331.31 US$4,096,121
2025-10-09 2025-10-09
B Purchase
63,391 +39.8%
437.08
US$1,382,134 		63,391 +39.8% 437.08 US$1,382,134
2025-10-09 2025-10-08
B Purchase
39,363 -41.2%
74.49
US$3,971,586 		39,363 -41.2% 74.49 US$3,971,586
2024-07-24 2024-07-24
B Purchase
52,300 +14.5%
1.93
US$101,038 		52,300 +14.5% 1.93 US$101,038
2024-07-24 2024-07-23
B Purchase
6,648 +1.9%
1.82
US$12,075 		6,648 +1.9% 1.82 US$12,075
2024-07-24 2024-07-22
B Purchase
41,052 +13.1%
1.74
US$71,500 		41,052 +13.1% 1.74 US$71,500
2023-05-11 2023-05-10
B Purchase
200,000 +177.0%
2.25
US$450,000 		200,000 +177.0% 2.25 US$450,000
2021-05-20 2021-05-18
B Purchase
50,000 +79.3%
3.98
US$199,000 		50,000 +79.3% 3.98 US$199,000
2020-05-22 2020-05-20
S Sale
8,447 -1.9%
3.64
US$30,739 		8,447 -1.9% 3.64 US$30,739
2020-02-11 2020-02-10
B Purchase
254,000 +138.4%
4.25
US$1,079,500 		254,000 +138.4% 4.25 US$1,079,500
2017-04-21 2017-04-19
B Purchase
10,000 +276.0%
10.00
US$100,000 		10,000 +276.0% 10.00 US$100,000